Azam Nahvi

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Richard A. Morgan, Mark E. Dudley, John R. Wunderlich et al. · Science · 2006 · 2.6K citations · Full text

Medicine, Immunology, Oncology +14

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins, Richard A. Morgan, Steven A. Feldman et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma

Ling Zhang, Richard A. Morgan, Joal D. Beane et al. · Clinical Cancer Research · 2015 · 452 citations · Full text

Medicine, Immunology, Oncology +17

A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, James C. Yang et al. · Journal of Immunotherapy · 2002 · 348 citations

Medicine, Immunology, Oncology +17

Relationship of p53 Overexpression on Cancers and Recognition by Anti-p53 T Cell Receptor-Transduced T Cells

Marc R. Theoret, Cyrille J. Cohen, Azam Nahvi et al. · Human Gene Therapy · 2008 · 44 citations · Full text

Life Sciences, Immunology, Oncology +17